Medline (NASDAQ:MDLN) Given Average Rating of "Moderate Buy" by Analysts

Key Points

• Analysts broadly favor Medline: Twenty-one analysts rate the stock a buy and two rate it a strong buy, producing a consensus “Moderate Buy” rating. The average 12-month price target is $47.42, well above the recent $31.64 price.
• Medline reported quarterly EPS of $0.50, beating the $0.32 consensus estimate by $0.18, while revenue reached $7.68 billion.
• The stock has declined from its 52-week high of $50.88 and trades near its $31.49 low; insiders sold 4.44 million shares worth approximately $158.3 million during the last quarter.

Medline (NASDAQ:MDLN - Get Free Report) has been given a consensus rating of "Moderate Buy" by the twenty-nine research firms that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, five have issued a hold rating, twenty-one have assigned a buy rating and two have given a strong buy rating to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $47.4231.

A number of equities research analysts have recently commented on MDLN shares. TD Cowen lowered their target price on Medline from $53.00 to $45.00 and set a "buy" rating on the stock in a research note on Monday, August 10th. Citigroup raised shares of Medline to a "strong-buy" rating in a report on Wednesday, August 5th. Evercore set a $39.00 price objective on Medline in a report on Thursday, August 6th. Stifel Nicolaus decreased their target price on Medline from $50.00 to $45.00 and set a "buy" rating for the company in a research report on Thursday, August 6th. Finally, Deutsche Bank Aktiengesellschaft set a $37.00 target price on Medline in a research note on Thursday, August 6th.

Medline Price Performance

Medline stock opened at $31.64 on Friday. Medline has a 52 week low of $31.49 and a 52 week high of $50.88. The company's 50 day moving average price is $36.21 and its two-hundred day moving average price is $39.27. The stock has a market cap of $41.60 billion and a P/E ratio of 40.05. The company has a quick ratio of 2.61, a current ratio of 4.33 and a debt-to-equity ratio of 0.66.

Medline (NASDAQ:MDLN - Get Free Report) last released its earnings results on Wednesday, August 5th. The company reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.32 by $0.18. The business had revenue of $7.68 billion during the quarter. On average, equities analysts predict that Medline will post 1.51 earnings per share for the current year.

Insider Transactions at Medline

In other Medline news, major shareholder Private Ltd Gic sold 100,000 shares of the company's stock in a transaction dated Friday, August 14th. The shares were sold at an average price of $35.80, for a total transaction of $3,580,000.00. Following the sale, the insider directly owned 22,802,482 shares of the company's stock, valued at $816,328,855.60. This represents a 0.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In the last quarter, insiders sold 4,438,896 shares of company stock valued at $158,259,454. Insiders own 0.81% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. Core Capital Management & Research inc. bought a new stake in Medline during the 2nd quarter valued at $96,000. Tidal Investments LLC bought a new position in shares of Medline in the second quarter worth $334,000. WINTON GROUP Ltd grew its position in shares of Medline by 1,263.0% in the second quarter. WINTON GROUP Ltd now owns 367,057 shares of the company's stock valued at $14,477,000 after purchasing an additional 340,127 shares in the last quarter. Engineers Gate Manager LP purchased a new position in shares of Medline in the second quarter valued at $3,194,000. Finally, Integrated Wealth Concepts LLC bought a new stake in shares of Medline during the 2nd quarter valued at $260,000.

Medline Company Profile

Medline Industries, Inc is a healthcare company that manufactures and distributes medical supplies and clinical products. Its offerings include surgical and exam gloves, personal protective equipment, operating-room supplies, wound-care products, patient-care items, laboratory products, apparel, and durable medical equipment.

The company serves hospitals, health systems, ambulatory surgery centers, physicians' offices, long-term-care facilities, home-health providers, and other healthcare organizations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.